Segment Reporting - Schedule of Information about Net Sales and Property and Equipment (Details) - USD ($)	3 Months Ended
	Apr. 30, 2026	Apr. 30, 2025	Jan. 31, 2026
Net Sales
Net sales total	$ 433,399	$ 667,432
Property and equipment, net of accumulated depreciation
Property and equipment, net of accumulated depreciation total	548,244		$ 567,255
Assets
Assets total	6,892,302		7,547,935
Reportable Subsegments [Member]
Net Sales
Net sales total	433,399	667,432
Property and equipment, net of accumulated depreciation
Property and equipment, net of accumulated depreciation total	548,244		567,255
Assets
Assets total	6,892,302		7,547,935
Corporate [Member] \| Reportable Subsegments [Member]
Assets
Assets total	3,818,051		4,437,703
Pocono Pharmaceuticals [Member] \| Reportable Subsegments [Member]
Assets
Assets total	1,825,258		1,820,731
4P Therapeutics [Member] \| Reportable Subsegments [Member]
Net Sales
Net sales total
Assets
Assets total	1,248,993		1,294,501
United States [Member] \| Reportable Subsegments [Member]
Net Sales
Net sales total	433,399	667,432
Property and equipment, net of accumulated depreciation
Property and equipment, net of accumulated depreciation total	548,244		567,255
Outside the United States [Member] \| Reportable Subsegments [Member]
Net Sales
Net sales total
Property and equipment, net of accumulated depreciation
Property and equipment, net of accumulated depreciation total